Healthcare - Biotechnology - NASDAQ - US
$ 4.31
-8.69 %
$ 304 M
Market Cap
-2.52
P/E
Price Target
Average
243.39%
Revenue Forecast
Estimate
--3.25%
EBIT
Estimate
--4.98%
Net Income
Estimate
--0.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
C4 Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for CCCC of $14.8 , with forecasts ranging from a low of $9 to a high of $20 .
CCCC Lowest Price Target
Wall Street Target
9 USD
108.82%
CCCC Average Price Target
Wall Street Target
14.8 USD
243.39%
CCCC Highest Price Target
Wall Street Target
20 USD
364.04%
REVENUE FORECAST
Revenue Forecast Chart CCCC
EBIT FORECAST
EBIT Forecast Chart CCCC
NET INCOME FORECAST
Net Income Chart CCCC